Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
Hari, Parameswaran, Reece, Donna E., Randhawa, Jasleen, Flomenberg, Neal, Howard, Dianna S., Badros, Ashrof Z., Rapoport, Aaron P., Meisenberg, Barry R., Filicko-Ohara, Joanne, Phillips, Gordon L., Vesole, David H.
Published in Bone marrow transplantation (Basingstoke) (01.02.2019)
Published in Bone marrow transplantation (Basingstoke) (01.02.2019)
Get full text
Journal Article
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
Barlogie, Bart, Desikan, Raman, Eddlemon, Paul, Spencer, Trey, Zeldis, Jerome, Munshi, Nikhil, Badros, Ashrof, Zangari, Maurizio, Anaissie, Elias, Epstein, Joshua, Shaughnessy, John, Ayers, Dan, Spoon, Dan, Tricot, Guido
Published in Blood (15.07.2001)
Published in Blood (15.07.2001)
Get full text
Journal Article
Final outcomes of escalated melphalan 280 mg/m 2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
Hari, Parameswaran, Reece, Donna E, Randhawa, Jasleen, Flomenberg, Neal, Howard, Dianna S, Badros, Ashrof Z, Rapoport, Aaron P, Meisenberg, Barry R, Filicko-Ohara, Joanne, Phillips, Gordon L, Vesole, David H
Published in Bone marrow transplantation (Basingstoke) (01.02.2019)
Get full text
Published in Bone marrow transplantation (Basingstoke) (01.02.2019)
Journal Article
Effect of the Proteasome Inhibitor Bortezomib in Combination with “DT-PACE” on Stem Cell Collection and Engraftment in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts)
Badros, Ashrof Z., Bolaños-Meade, Javier, Rapoport, Aaron, Ratterree, Bashi, Natt, Sabrina, Ruehle, Kathy, McNamara, Kathy, Cox, Edmund, Westphal, Sandy, Fenton, Robert, Meisenberg, Barry
Published in Blood (16.11.2004)
Published in Blood (16.11.2004)
Get full text
Journal Article
Phase II Trial of Oblimersen Sodium (G3139), Dexamethasone (Dex) and Thalidomide (Thal) in Relapsed Multiple Myeloma Patients (Pts)
Badros, Ashrof Z., Goloubeva, Olga, Ratterree, Bashi, Natt, Sabrina, Rapoport, Aaron, Bolaños-Meade, Javier, Zhang, Ben, Zeldis, Jerry, Frankel, Stanley, Meisenberg, Barry, Zwiebel, James, Flaws, J., Tomic, D., Fenton, Robert
Published in Blood (16.11.2004)
Published in Blood (16.11.2004)
Get full text
Journal Article